022 Remission, Relapse and Reality Understanding the R-Words in Myeloma Podcast Por  arte de portada

022 Remission, Relapse and Reality Understanding the R-Words in Myeloma

022 Remission, Relapse and Reality Understanding the R-Words in Myeloma

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible

Dr Jam & Sally unpack what remission, relapse and refractory disease truly mean for people living with myeloma — and explore how close we are to talking about cure.

📌Key Takeaways:

  • Remission ≠ cure – myeloma can be controlled for years, even if it never fully disappears.
  • Monitoring matters – blood tests, bone marrow checks and scans together tell the full story.
  • Hope is growing – deeper remissions and new tests mean “functional cure” is now within reach.

For extra content and more resources, please visit our website: https://www.themyelomaminutes.com/

This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns

ABOUT YOUR HOSTS

Dr. Jam Kothari

Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.

Dr. Sally Moore

Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients. She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.

Todavía no hay opiniones